TD | Jotup

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Retrieved on:

Friday, October 27, 2023

MGD, Fireside chats, Conference, Therapy, TD, Pharmaceutical industry

BOSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences:

Key Points:

BOSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences:
TD Cowen 7th Annual Fall Oncology Innovation Summit (virtual) – Fireside Chat, November 3, 2023, 1:00 p.m.
ET
Jefferies London Healthcare Conference (London, UK) – Investor meetings, November 14-15, 2023
The webcasted presentation will be accessible via the “Events & Presentations” section of Monte Rosa’s website at ir.monterosatx.com , and an archived version will be made available for 90 days following the presentation.

CORUS ENTERTAINMENT ANNOUNCES AMENDMENT OF CREDIT FACILITIES

Retrieved on:

Friday, October 27, 2023

Credit, Term, Line of credit, Maternity Benefit (Amendment) Act, 2017, Primary Dealer Credit Facility, TD, Corus, TSX, Amendment, RBC Capital Markets, TD Securities, Security (finance)

TORONTO, Oct. 27, 2023 /PRNewswire/ - Corus Entertainment Inc. ("Corus" or the "Company") (TSX: CJR.B) announced today that it has completed an agreement to amend (the "Amendment") its Sixth Amended and Restated Credit Agreement with its bank group, led by RBC Capital Markets and TD Securities, dated March 18, 2022 as amended February 17, 2023 (the "Credit Facility").

Key Points:

TORONTO, Oct. 27, 2023 /PRNewswire/ - Corus Entertainment Inc. ("Corus" or the "Company") (TSX: CJR.B) announced today that it has completed an agreement to amend (the "Amendment") its Sixth Amended and Restated Credit Agreement with its bank group, led by RBC Capital Markets and TD Securities, dated March 18, 2022 as amended February 17, 2023 (the "Credit Facility").
Pursuant to the Amendment, the maximum Total Debt to Cash Flow Ratio required under the financial covenants is increased through and including August 31, 2024, mandatory quarterly repayments of the Term Facility are re-introduced, certain conditions related to the use of proceeds on asset disposals are changed and additional restrictions on Distributions are introduced.
All terms are defined in the Credit Facility.

Manulife, The Co-Operators, TD Insurance and more in Toronto for The Future of Insurance Canada 2023

Retrieved on:

Friday, October 20, 2023

Internet of things, Fintech, WTW, Commercial, The Co-operators, Apollo insurance covers, Reuters, Business, TD, Sun Life Financial, UNI Financial Cooperation, AI, Partnership, Insurance, Potential, Uncertainty, Management, Manulife

Amplified operational costs, higher customer expectations, and accelerated digital demands only scratch the surface of the disruption that insurers must navigate.

Key Points:

Amplified operational costs, higher customer expectations, and accelerated digital demands only scratch the surface of the disruption that insurers must navigate.
To thrive, insurers must utilize uncertainty as an opportunity to transform the entire value chain.
That is why, Reuters Events will be hosting Canada's most senior insurance event, The Future of Insurance Canada 2023.
Latest speakers: AVP Global Program Management, Manulife, Director Data Science and Business intelligence, Allstate Canada, Chief Underwriting Officer, APOLLO Insurance, AVP Architecture & Design, The Cooperators
Recent confirmed attendance from WTW, TD Insurance, APOLLO Insurance, Markel Canada, Everest Canada, Lloyds Canada, Old Republic Insurance, Zensurance, Sun Life, Great-West Life Co and more!

CSX and BRS Reach Second Agreement on Paid Sick Leave

Retrieved on:

Wednesday, October 25, 2023

IBEW, CSX Corporation, BRS, Brotherhood of Railroad Signalmen, CSX, L&N, IAM, BRC, Brotherhood, SCL, TD, NCFO, Sick leave, Health insurance, Nursing

JACKSONVILLE, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) is announcing the ratification of a paid sick leave agreement covering approximately 200 employees represented by the Brotherhood of Railroad Signalmen (BRS) on the company’s L&N property.

Key Points:

JACKSONVILLE, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) is announcing the ratification of a paid sick leave agreement covering approximately 200 employees represented by the Brotherhood of Railroad Signalmen (BRS) on the company’s L&N property.
The ratification follows another recent agreement with the BRS covering nearly 400 employees on the SCL property.
CSX continues to build on series of successful negotiations with various railroad unions to provide paid sick leave.
This includes agreements reached earlier this year with the BMWED, BRC, SMART-TD, IAM, NCFO and IBEW unions, providing paid sick leave for thousands of railroad workers.

Ninepoint Partners Closes 2023 Short Duration Flow-Through LP With Over $20 Million In Proceeds

Retrieved on:

Tuesday, October 24, 2023

Sale, Mining, CIBC, Real assets, Geology, News, Investment, Prospectus, Partnership, Flow-through share, Digital asset, Master limited partnership, RBC Dominion Securities, TD, Security (finance), Unit, Sprot

TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”) is pleased to announce that the Ninepoint 2023 Short Duration Flow-Through Limited Partnership (the “Partnership”) has completed the second and final closing in connection with its offering of Class A and Class F limited partnership Units (the “Units”) pursuant to a prospectus dated September 27, 2023.

Key Points:

TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”) is pleased to announce that the Ninepoint 2023 Short Duration Flow-Through Limited Partnership (the “Partnership”) has completed the second and final closing in connection with its offering of Class A and Class F limited partnership Units (the “Units”) pursuant to a prospectus dated September 27, 2023.
The Partnership raised $6,553,200 on the sale of an additional 262,128 units for aggregate gross proceeds of $20,321,675.
The Partnership intends to provide liquidity to limited partners through a tax-deferred rollover to the Ninepoint Resource Fund Class in the period between January 15, 2025 and February 28, 2025.
Since its inception in 2017, Ninepoint has successfully raised more Flow-Through Fund capital than any other asset manager in Canada.

Ultragenyx Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on:

Monday, October 23, 2023

Sale, Goldman Sachs, Security (finance), Telephone, Attention, Exercise, Prospectus, J.P. Morgan & Co., TD, Broadridge Financial Solutions, Lexington Avenue, Exchange, BofA Securities

The estimated net proceeds to the company, after deducting underwriting discounts and commissions and other offering expenses payable by the company, were approximately $326.1 million.

Key Points:

The estimated net proceeds to the company, after deducting underwriting discounts and commissions and other offering expenses payable by the company, were approximately $326.1 million.
J.P. Morgan, Goldman Sachs & Co. LLC, BofA Securities, and TD Cowen acted as joint book-running managers for the offering.
The securities described above were offered by Ultragenyx Pharmaceutical Inc. pursuant to a registration statement previously filed with the Securities and Exchange Commission that became automatically effective on February 12, 2021.
A final prospectus supplement and accompanying prospectus were filed with the SEC and available for free on the SEC’s website at http://www.sec.gov .

Harpoon Therapeutics Announces Up to $150 Million Private Placement

Retrieved on:

Monday, October 23, 2023

Sale, INVU (song), TD, PIPE, Therapy, SAN, Security (finance), Citadel

Each full warrant will represent the right to purchase one share of the Company’s common stock at an exercise price of $5.8345 per share.

Key Points:

Each full warrant will represent the right to purchase one share of the Company’s common stock at an exercise price of $5.8345 per share.
The accompanying warrants will be exercisable upon issuance for a period of three years following the date of issuance.
TD Cowen is acting as the lead placement agent for the PIPE financing.
Canaccord Genuity and H.C. Wainwright & Co. are also acting as placement agents for the PIPE financing.

Arcutis Announces Pricing of $100 Million Public Offering

Retrieved on:

Friday, October 20, 2023

Arcutis is selling 32,500,000 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 7,500,000 shares of common stock in the offering.

Key Points:

Arcutis is selling 32,500,000 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 7,500,000 shares of common stock in the offering.
The shares of common stock are being sold at a public offering price of $2.50 per share and the pre-funded warrants are being sold at a public offering price of $2.4999 per pre-funded warrant, which represents the per share public offering price for each share of common stock less the $0.0001 per share exercise price for each pre-funded warrant.
All shares of common stock and pre-funded warrants to be sold in the offering are being offered by Arcutis.
In addition, Arcutis has granted the underwriters a 30-day option to purchase up to an additional 6,000,000 shares of its common stock at the public offering price per share, less underwriting discounts and commissions.

Arcutis Announces Proposed Public Offering

Retrieved on:

Thursday, October 19, 2023

Varick Street, Sale, Morgan Stanley, Guggenheim Partners, The 8th Floor, Telephone, Attention, Floor, Prospectus, 2nd Floor, TD, Lexington Avenue, Madison Avenue, Guggenheim, Security (finance)

All of the shares of common stock and pre-funded warrants in this offering are being sold by Arcutis.

Key Points:

All of the shares of common stock and pre-funded warrants in this offering are being sold by Arcutis.
The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
In addition, Arcutis intends to grant the underwriters a 30-day option to purchase up to an additional $15.0 million of shares of its common stock at the public offering price per share.
Morgan Stanley, TD Cowen and Guggenheim Securities are acting as joint lead bookrunning managers for the proposed offering.

CSX and BRS Reach Agreement on Paid Sick Leave

Retrieved on:

Thursday, October 19, 2023

Rail transport, IBEW, Signalman, Workforce, CSX Corporation, Brotherhood of Railroad Signalmen, CSX, IAM, BRC, Brotherhood, SCL, TD, NCFO, Sick leave, Health insurance

JACKSONVILLE, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) is pleased to announce the ratification of a paid sick leave agreement with the SCL property for the Brotherhood of Railroad Signalmen covering nearly 400 employees.

Key Points:

JACKSONVILLE, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) is pleased to announce the ratification of a paid sick leave agreement with the SCL property for the Brotherhood of Railroad Signalmen covering nearly 400 employees.
The agreement underscores CSX's commitment to the welfare and well-being of its workforce.
It provides a sick leave package that ensures employees can take necessary time off from work to recover from illness without worrying about their financial stability.
This includes agreements reached earlier this year with the BMWED, BRC, SMART-TD, IAM, NCFO and IBEW unions, providing paid sick leave for thousands of railroad workers across the country.